Testing the utility of site-specific recombinases for manipulations of genome of moenomycin producer Streptomyces ghanaensis ATCC14672

Journal of Applied Genetics

Volumn 56, Issue 4, 2015, Pages 547-550

  Lopatniuk, M ^a,b   Ostash, B ^a   Makitrynskyy, R ^a   Walker, S ^c   Luzhetskyy, A ^b   Fedorenko, V ^a  

^a IVAN FRANKO NATIONAL UNIVERSITY OF LVIV   (Ukraine)

^b SAARLAND UNIVERSITY   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Genome engineering; Moenomycin; SSRs; Streptomyces ghanaensis

Indexed keywords

BAMBERMYCIN; CRE RECOMBINASE; RECOMBINASE; ANTIINFECTIVE AGENT; DNA POLYMERASE; OLIGOSACCHARIDE; SITE-SPECIFIC RECOMBINASE;

ARTICLE; GENE DOSAGE; GENE SEQUENCE; MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; STREPTOMYCES; STREPTOMYCES GHANAENSIS; BACTERIAL GENOME; BIOSYNTHESIS; CHEMISTRY; GENETIC ENGINEERING; GENETICS; PROCEDURES;

ANTI-BACTERIAL AGENTS; DNA NUCLEOTIDYLTRANSFERASES; GENETIC ENGINEERING; GENOME, BACTERIAL; OLIGOSACCHARIDES; STREPTOMYCES;

EID: 84945445343     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13353-015-0283-8     Document Type: Article

References (13)

1. Fedoryshyn M, Petzke L, Welle E, Bechthold A, Luzhetskyy A (2008) Marker removal from actinomycetes genome using Flp recombinase. Gene 419:43–47. doi:10.1016/j.gene.2008.04.011
2. Gampe CM, Tsukamoto H, Wang A, Walker S, Kahne D (2011) Modular synthesis of diphospholipid oligosaccharide fragments of the bacterial cell wall and their use to study the mechanism of moenomycin and other antibiotics. Tetrahedron 67:9771–9778. doi:10.1016/j.tet.2011.09.114
3. Makitrynskyy R, Rebets Y, Ostash B, Zaburannyi N, Rabyk M, Walker S, Fedorenko V (2010) Genetic factors that influence moenomycin production in streptomycetes. J Ind Microbiol Biotechnol 37:559–566
4. Makitrynskyy R, Ostash B, Tsypik O, Rebets Y, Doud E, Meredith T, Luzhetskyy A, Bechthold A, Walker S, Fedorenko V (2013) Pleiotropic regulatory genes bldA, adpA and absB are implicated in production of phosphoglycolipid antibiotic moenomycin. Open Biol 3:130121. doi:10.1098/rsob.130121
5. Ostash B, Walker S (2010) Moenomycin family antibiotics: chemical synthesis, biosynthesis, biological activity. Nat Prod Rep 27:1594–1617. doi:10.1039/c001461n
6. Ostash B, Saghatelian A, Walker S (2007) A streamlined metabolic pathway for the biosynthesis of moenomycin A. Chem Biol 14:257–267. doi:10.1016/j.chembiol.2007.01.008
7. Ostash B, Makitrinskyy R, Walker S, Fedorenko V (2009) Identification and characterization of Streptomyces ghanaensis ATCC14672 integration sites for three actinophage-based plasmids. Plasmid 61:171–175. doi:10.1016/j.plasmid.2008.12.002
8. Ostash B, Campbell J, Luzhetskyy A, Walker S (2013) MoeH5: a natural glycorandomizer from the moenomycin biosynthetic pathway. Mol Microbiol 90:1324–1338. doi:10.1111/mmi.12437
9. Pfaller MA (2006) Flavophospholipol use in animals: positive implications for antimicrobial resistance based on its microbiologic properties. Diagn Microbiol Infect Dis 56:115–1121. doi:10.1016/j.diagmicrobio.2006.03.014
10. Rebets Y, Lupoli T, Qiao Y, Schirner K, Villet R, Hooper D, Kahne D, Walker S (2014) Moenomycin resistance mutations in Staphylococcus aureus reduce peptidoglycan chain length and cause aberrant cell division. ACS Chem Biol 9:459–467. doi:10.1021/cb4006744
11. Schweizer HP (2003) Applications of the Saccharomyces cerevisiae Flp-FRT system in bacterial genetics. J Mol Microbiol Biotechnol 5:67–77. doi:10.1159/000069976
12. Siegl T, Luzhetskyy A (2012) Actinomycetes genome engineering approaches. Antonie Van Leeuwenhoek 102(3):503–516. doi:10.1007/s10482-012-9795-y
13. Welzel P (2005) Syntheses around the transglycosylation step in peptidoglycan biosynthesis. Chem Rev 105:4610–4660. doi:10.1021/cr040634e